Maternal pruritus gravidarum and its long-term effect on dermatological morbidity in the offspring

Abstract Purpose Pruritus gravidarum is characterized by general pruritus in the absence of primary skin lesions. In this study, we sought to evaluate whether the offspring (≤ 18 years) of mothers diagnosed with pruritus gravidarum, are at increased risk of long-term dermatology-related hospitalization. Methods A population-based, retrospective cohort study of all singleton deliveries between 1991 and 2021 was conducted at a tertiary medical center. Offspring of mothers diagnosed with pruritus gravidarum were compared to offspring of non-exposed mothers. First admission involving dermatological morbidity of the offspring were analyzed using ICD-9 codes. Kaplan-Meier survival curves were used to compare the cumulative hospitalization incidence between the groups and Cox regression models were utilized to adjust for confounding variables. Results A total of 849 women out of 356,356 deliveries that fulfilled the inclusion criteria were diagnosed with pruritus gravidarum during pregnancy (0.23%). Among offspring to mothers with pruritus gravidarum versus non-pruritus gravidarum mothers, hospitalization rates involving dermatological morbidity, were higher (7.1% vs. 4.6%, p < .001) a finding that was consistent with the Kaplan-Meier survival curve (Log rank p = .002). In the Cox regression model, pruritus gravidarum was found to be a significant independent risk factor for dermatological-related hospitalizations in the offspring after controlling for gestational age, hypertensive disorders, diabetic disorders, meconium-stained amniotic fluid exposure and fertility treatments (adjusted HR = 1.44, 95% CI 1.12–1.85, p = .004). Conclusions Maternal pruritus gravidarum is an independent risk factor for long-term dermatology-related hospitalization in the offspring up to the age of 18 years.

[1]  E. Sheiner,et al.  Maternal term pruritus and long-term neuropsychiatric hospitalizations of the offspring , 2022, Archives of Gynecology and Obstetrics.

[2]  T. Hoashi,et al.  The Roles of Sex Hormones in the Course of Atopic Dermatitis , 2019, International journal of molecular sciences.

[3]  T. Hashimoto,et al.  Itch: From mechanism to (novel) therapeutic approaches , 2018, The Journal of allergy and clinical immunology.

[4]  A. Harlev,et al.  Long‐term pediatric skin eruption‐related hospitalizations in offspring conceived via fertility treatment , 2018, International journal of dermatology.

[5]  A. Reich,et al.  Prevalence and Relevance of Pruritus in Pregnancy , 2017, BioMed research international.

[6]  P. Elsner,et al.  Cutaneous Manifestations of Diabetes Mellitus: A Review , 2017, American Journal of Clinical Dermatology.

[7]  Chen-Sheng Chen,et al.  Impaired microvascular flow motion in subclinical diabetic feet with sudomotor dysfunction. , 2012, Microvascular research.

[8]  E. Sheiner,et al.  Risk factors for intrapartum fetal death and trends over the years , 2012, Archives of Gynecology and Obstetrics.

[9]  E. Sheiner,et al.  Risk factors for intrauterine fetal death (1988–2009) , 2011, Journal of Maternal-Fetal & Neonatal Medicine.

[10]  C. Ambros-Rudolph Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy , 2011, Annals of dermatology.

[11]  J. Ring,et al.  Gender difference, sex hormones, and immediate type hypersensitivity reactions , 2008, Allergy.

[12]  M. Denda,et al.  Paradoxical effects of β‐estradiol on epidermal permeability barrier homeostasis , 2007 .

[13]  T. Midoro-Horiuti,et al.  Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. , 2007, Molecular immunology.

[14]  T. Midoro-Horiuti,et al.  Environmental Estrogens Induce Mast Cell Degranulation and Enhance IgE-Mediated Release of Allergic Mediators , 2006, Environmental Health Perspectives.

[15]  M. Katz,et al.  Pregnancy outcome in women with pruritus gravidarum. , 2006, Journal of reproductive medicine.

[16]  E. Sheiner,et al.  Pregnancy outcome of patients with pruritic urticarial papules and plaques of pregnancy , 2006, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[17]  J. Roujeau,et al.  French people and skin diseases: results of a survey using a representative sample. , 2003, Archives of dermatology.

[18]  J. Schmutz [Physiological skin changes during pregnancy]. , 2003, Presse medicale.

[19]  A. Carruthers,et al.  The Skin in Pregnancy , 2002, Journal of cutaneous medicine and surgery.

[20]  S. Habeebullah,et al.  Pruritus Gravidarum: A Clinical and Laboratory Study , 1998, The Journal of dermatology.

[21]  Y. Thaipisuttikul Pruritic Skin Diseases in the Elderly , 1998, The Journal of dermatology.

[22]  L. Vaillant,et al.  Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women. , 1997, Archives of dermatology.

[23]  N. Tryding,et al.  Cholestasis of Pregnancy: Clinical and Laboratory Studies , 1986 .

[24]  G. K. Malik,et al.  Maternal serum alkaline phosphatase and fetal maturity , 1981, Indian journal of pediatrics.

[25]  J. Ribalta,et al.  PREVALENCE OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY IN CHILE , 1978, Annals of internal medicine.

[26]  M. Sleisenger,et al.  Recurrent cholestatic jaundice of pregnancy with demonstrated estrogen sensitivity. , 1967, The American journal of medicine.

[27]  M. Osler,et al.  Icterus and pregnancy. , 1967, American journal of obstetrics and gynecology.

[28]  M. N. Mueller,et al.  ESTROGEN PHARMACOLOGY. I. THE INFLUENCE OF ESTRADIOL AND ESTRIOL ON HEPATIC DISPOSAL OF SULFOBROMOPHTHALEIN (BSP) IN MAN. , 1964, The Journal of clinical investigation.

[29]  W. Montagna,et al.  Studies of skin of fetus and the child. The distribution of alkaline phosphatase in the skin of the fetus. , 1963, Archives of dermatology.

[30]  G. Koren,et al.  Pruritus in pregnancy: treatment of dermatoses unique to pregnancy. , 2013, Canadian family physician Medecin de famille canadien.

[31]  T. Midoro-Horiuti,et al.  Estradiol activates mast cells via a non-genomic estrogen receptor- α and calcium influx , 2008 .

[32]  T. Midoro-Horiuti,et al.  Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. , 2007, Environmental health perspectives.

[33]  N. Nagelkerke,et al.  Does paternal antigen-induced secretion of interleukin-10 by T regulatory cells mediate the birth order effect? , 2006, Medical hypotheses.

[34]  D. Kerr,et al.  Skin-Related Complications of Insulin Therapy , 2003 .

[35]  D. Kerr,et al.  Skin-related complications of insulin therapy: epidemiology and emerging management strategies. , 2003, American journal of clinical dermatology.

[36]  C. Ellis,et al.  Physiologic skin changes in pregnancy. , 1984, Journal of the American Academy of Dermatology.

[37]  M. Sleisenger,et al.  Idiopathic cholestasis of pregnancy. The response to challenge with the synthetic estrogen, ethinyl estradiol. , 1967, New England Journal of Medicine.